Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020375

Expand all

CLIMARA (ESTRADIOL)
0.025MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.025MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N020375
Product Number: 004
Approval Date: Mar 5, 1999
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLIMARA (ESTRADIOL)
0.0375MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.0375MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N020375
Product Number: 005
Approval Date: May 27, 2003
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLIMARA (ESTRADIOL)
0.05MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.05MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N020375
Product Number: 001
Approval Date: Dec 22, 1994
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLIMARA (ESTRADIOL)
0.06MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.06MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020375
Product Number: 006
Approval Date: May 27, 2003
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLIMARA (ESTRADIOL)
0.075MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.075MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB2
Application Number: N020375
Product Number: 003
Approval Date: Mar 23, 1998
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information

CLIMARA (ESTRADIOL)
0.1MG/24HR
Marketing Status: Prescription

Active Ingredient: ESTRADIOL
Proprietary Name: CLIMARA
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 0.1MG/24HR
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB2
Application Number: N020375
Product Number: 002
Approval Date: Dec 22, 1994
Applicant Holder Full Name: BAYER HEALTHCARE PHARMACEUTICALS INC
Marketing Status:  Prescription
Patent and Exclusivity Information